Supreme Court Denies Certiorari To FTC v. Schering-Plough
This article was originally published in The Pink Sheet Daily
Executive Summary
The high court denies the Federal Trade Commission’s petition to hear the case regarding issues raised by brand companies’ reverse payments to generic firms.
You may also be interested in...
FTC “Barrs” Firm From Anticompetitive Agreements
Federal Trade Commission gets rare victory in settlement with Barr over charges that cash payment delayed entry of generic Ovcon.
FTC “Barrs” Firm From Anticompetitive Agreements
Federal Trade Commission gets rare victory in settlement with Barr over charges that cash payment delayed entry of generic Ovcon.
Pharmas Should Be Less Aggressive With Reverse Payments, Former FTC Counsel Advises
Payments to delay generic entry could be banned under pending legislation before Congress.